Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Mutation of GATA3 in human breast tumors.

Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM.

Oncogene. 2004 Oct 7;23(46):7669-78.

PMID:
15361840
2.

Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.

Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA, McWilliams R, Rigden S, Sampson J, Williams AJ, Thakker RV.

J Biol Chem. 2004 May 21;279(21):22624-34. Epub 2004 Feb 24.

3.

GATA3 haplo-insufficiency causes human HDR syndrome.

Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K.

Nature. 2000 Jul 27;406(6794):419-22.

PMID:
10935639
4.

Structure and expression of the human GATA3 gene.

Labastie MC, Bories D, Chabret C, Grégoire JM, Chrétien S, Roméo PH.

Genomics. 1994 May 1;21(1):1-6.

PMID:
8088776
5.

Identification of a novel insertion mutation in GATA3 with HDR syndrome.

Mino Y, Kuwahara T, Mannami T, Shioji K, Ono K, Iwai N.

Clin Exp Nephrol. 2005 Mar;9(1):58-61.

PMID:
15830275
6.
7.

GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.

Gaynor KU, Grigorieva IV, Allen MD, Esapa CT, Head RA, Gopinath P, Christie PT, Nesbit MA, Jones JL, Thakker RV.

Horm Cancer. 2013 Jun;4(3):123-39. doi: 10.1007/s12672-013-0138-x. Epub 2013 Feb 22.

PMID:
23435732
8.

ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.

Johnstone CN, Castellví-Bel S, Chang LM, Bessa X, Nakagawa H, Harada H, Sung RK, Piqué JM, Castells A, Rustgi AK.

Gene. 2004 Jul 7;336(1):59-71.

PMID:
15225876
9.

Critical YxKxHxxxRP motif in the C-terminal region of GATA3 for its DNA binding and function.

Shinnakasu R, Yamashita M, Shinoda K, Endo Y, Hosokawa H, Hasegawa A, Ikemizu S, Nakayama T.

J Immunol. 2006 Nov 1;177(9):5801-10.

10.

GATA3 abnormalities and the phenotypic spectrum of HDR syndrome.

Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T.

J Med Genet. 2001 Jun;38(6):374-80.

11.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

12.

The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL.

Breast Cancer Res Treat. 1993;26(2):191-202.

PMID:
8219256
13.

Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.

Ali A, Christie PT, Grigorieva IV, Harding B, Van Esch H, Ahmed SF, Bitner-Glindzicz M, Blind E, Bloch C, Christin P, Clayton P, Gecz J, Gilbert-Dussardier B, Guillen-Navarro E, Hackett A, Halac I, Hendy GN, Lalloo F, Mache CJ, Mughal Z, Ong AC, Rinat C, Shaw N, Smithson SF, Tolmie J, Weill J, Nesbit MA, Thakker RV.

Hum Mol Genet. 2007 Feb 1;16(3):265-75. Epub 2007 Jan 8.

14.

Transcription factor GATA3 and the human HDR syndrome.

Van Esch H, Devriendt K.

Cell Mol Life Sci. 2001 Aug;58(9):1296-300. Review.

PMID:
11577985
15.

Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells.

Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM.

Genes Chromosomes Cancer. 2000 Dec;29(4):356-62.

PMID:
11066082
16.

Molecular cloning of human er1 cDNA and its differential expression in breast tumours and tumour-derived cell lines.

Paterno GD, Mercer FC, Chayter JJ, Yang X, Robb JD, Gillespie LL.

Gene. 1998 Nov 5;222(1):77-82.

PMID:
9813250
17.

Gene expression analysis of Gata3-/- mice by using cDNA microarray technology.

Airik R, Kärner M, Karis A, Kärner J.

Life Sci. 2005 Apr 15;76(22):2559-68.

PMID:
15769480
18.

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. Epub 2005 Jan 28.

PMID:
15860260
19.
20.

Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.

Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG.

Cancer Res. 2005 Dec 15;65(24):11259-64.

Items per page

Supplemental Content

Write to the Help Desk